V. Servent

Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study

Pierre Soubeyran, Carine Bellera, Jean Goyard et al. · PLoS ONE · 2014 · 579 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Javier Cortés, P. Fumoleau, Giulia Bianchi et al. · Journal of Clinical Oncology · 2012 · 246 citations · Full text

Medicine, Oncology, Pharmacology +17

Validation of the G8 screening tool in geriatric oncology: The ONCODAGE project.

Pierre Soubeyran, Carine Bellera, Jean Goyard et al. · Journal of Clinical Oncology · 2011 · 156 citations

Medicine, Geriatric Medicine, Oncology +16

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 128 citations

Medicine, Oncology, Breast Oncology +9

Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers’ experience

B. Cutuli, C. Cohen-Solal-Le Nir, B. De Lafontan et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 127 citations

Medicine, Oncology, Surgery +12